We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$970M
AUM Growth
+$46.5M
Cap. Flow
-$12.4M
Cap. Flow %
-1.28%
Top 10 Hldgs %
72%
Holding
47
New
11
Increased
7
Reduced
11
Closed
10

Top Buys

1
KYNB
Kyntra Bio
KYNB
+$58.8M
2
MORF
Morphic Holding, Inc. Common Stock
MORF
+$42.9M
3
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
+$34.9M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$26.8M
5
CYCN icon
Cyclerion Therapeutics
CYCN
+$11M

Top Sells

1
ASND icon
Ascendis Pharma A/S
ASND
+$42.5M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$31.3M
3
ARGX icon
argenx
ARGX
+$31M
4
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$24.9M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$21M

Sector Composition

1 Healthcare 88.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRIS icon
26
Curis
CRIS
$9.14M
$5.55M 0.57%
7,456
– –
NGNE icon
27
Neurogene
NGNE
$789M
$5.35M 0.55%
113,294
– –
RYTM icon
28
Rhythm Pharmaceuticals
RYTM
$7.51B
$4.91M 0.51%
223,167
-177,671
-44% -$4.49M
SLDB icon
29
Solid Biosciences
SLDB
$948M
$4.75M 0.49%
+55,133
New +$6.01M
NGM
30
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.64M 0.48%
+316,900
New +$4.64M
KZR
31
DELISTED
Kezar Life Sciences
KZR
$4.5M 0.46%
58,329
-27,318
-32% -$4.25M
KDNY
32
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.71M 0.28%
352,284
-35,594
-9% -$542K
VCEL icon
33
Vericel Corp
VCEL
$2.39B
$2.48M 0.26%
131,001
– –
SYRS
34
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.3M 0.24%
+24,848
New +$1.73M
RGLS
35
DELISTED
Regulus Therapeutics
RGLS
$1.39M 0.14%
+111,111
New +$1.28M
GMDA
36
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$265K 0.03%
+52,120
New +$409K
TCRR
37
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$231K 0.02%
+16,114
New +$257K
ABUS icon
38
Arbutus Biopharma
ABUS
$889M
– –
-2,172,883
Closed -$7.78M
ARVN icon
39
Arvinas
ARVN
$532M
– –
-50,000
Closed -$738K
ASMB icon
40
Assembly Biosciences
ASMB
$533M
– –
-96,133
Closed -$18.3M
ASND icon
41
Ascendis Pharma A/S
ASND
$17.5B
– –
-360,819
Closed -$42.5M
DNTH icon
42
Dianthus Therapeutics
DNTH
$5.52B
– –
-79,862
Closed -$21M
RCKT icon
43
Rocket Pharmaceuticals
RCKT
$401M
– –
-450,000
Closed -$7.89M
SRRK icon
44
Scholar Rock
SRRK
$6.45B
– –
-338,668
Closed -$6.36M
ZLAB icon
45
Zai Lab
ZLAB
$2.32B
– –
-78,519
Closed -$2.32M
MYOK
46
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-478,574
Closed -$24.9M
SNNA
47
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
– –
-800,000
Closed -$1.86M
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return